Close Menu

NEW YORK (GenomeWeb) – MGI, a subsidiary of BGI, has received the medical device registration certificate from the China Food and Drug Administration for its two next-generation sequencers, MGISEQ-2000 and MGISEQ-200. The certification enables healthcare organizations to use the instruments for clinical purposes.

According to the company, the MGISEQ-2000 instrument has two different flow cells that enable users to combine different operating modes and can generate 1,080 gigabases of sequencing data within 48 hours. MGISEQ-200 can produce 60 gigabases of data in less than 48 hours.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.